{
    "title": "Pioneering cancer gene therapy by Novartis backed by U.S. panel",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4690564/Pioneering-cancer-gene-therapy-Novartis-backed-U-S-panel.html",
    "date": "2017-07-12",
    "keywords": [
        "drug",
        "therapy",
        "cancer",
        "novartis",
        "panel",
        "tisagenlecleucel",
        "bcell",
        "form",
        "fda",
        "inc",
        "bodys",
        "immune",
        "cell",
        "percent",
        "chemotherapy",
        "lymphoma",
        "syndrome",
        "backing",
        "way",
        "gene",
        "food",
        "administration",
        "leukemia",
        "childhood",
        "agency",
        "end",
        "approval",
        "pharma",
        "juno",
        "bluebird",
        "bio",
        "antigen",
        "receptor",
        "tcell",
        "success",
        "cancerfighting",
        "technique",
        "field",
        "number",
        "investment",
        "type",
        "forward",
        "reni",
        "benjamin",
        "analyst",
        "raymond",
        "glimpse",
        "perspective",
        "space",
        "trial",
        "remission",
        "infusion",
        "chance",
        "diffuse",
        "part",
        "landscape",
        "company",
        "product",
        "engineering",
        "patient",
        "process",
        "time",
        "half",
        "complication",
        "cytokine",
        "release",
        "crs",
        "system",
        "condition",
        "concern",
        "term",
        "risk",
        "reporting",
        "clarke",
        "washington",
        "editing",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}